Independent Review of University Spinout Companies: The University of Manchester Response
The University of Manchester welcomes the Independent Review of University Spinout Companies published today (21st November).
PharmaKure Submits MHRA Clinical Trial Application
PharmaKure submits MHRA CTA for Phase 2a Clinical Trial of PK051 in patients with mild cognitive impairment
The University of Manchester’s Innovation Factory highly rated by Research England
The University of Manchester’s Innovation Factory highly rated by Research England in IP and commercialisation.
Link Biologics and Théa Open Innovation enter partnership to develop Link_TSG6 for Dry Eye Disease
UoM spinout Link Biologics Limited and Théa Open Innovation have announced that they have entered into an agreement to co-develop Link_TSG6 for the treatment of Dry Eye Disease (DED) and other ophthalmology indications.
Commercialise Your Cancer Research - Out of the Lab, and in to the Treatment Room.
Do you have a cancer research project that could improve early diagnosis, treatment or preventative care? Find out here how to commercialise that research in order to bring it to market, and create world-changing impact.
Celebrating collaboration across the Greater Manchester ecosystem
The ERDF Research & Innovation (R&I) Health Accelerator programme is coming to a close, having supported over 60 companies, creating 35 research collaborations and delivering more than 25 events across the city-region and beyond.
Pawel Piotrowicz gives a talk to the DCS on IPRs
Pawel Piotrowicz (UK and European Patent Attorney, Venner Shipley) discusses the why, how and when with regards to protecting your intellectual property in Computer Science.
New independent national report spotlights rapid recent spinout growth
The Royal Academy of Engineering’s annual independent report, Spotlight on Spinouts 2023, reveals that The University of Manchester (UoM) has shown the greatest growth among UK universities in the proportions of their spinout populations in the past two years.
FSE Innovation Academy Day
On Wednesday 24th May 2023, we held an event for academics in the Faculty of Science and Engineering to hear from experts on commercialising translational research. Click here to hear from investors, spinout founders, Luke Georghiou and more.
World IP Day: Women and IP
This year, on World IP Day, we celebrate Women and IP. Take a look at some of our ground-breaking female-led projects here.
Leading Universities and Investors Launch Set of Recommendations for the Innovation Sector
The UK’s potential as a Science Superpower has been given a significant boost today with the launch of The USIT Guide, a unique guidance that will accelerate and support the founding of a new generation of start-ups.
Complement Therapeutics Secures €72 Million in Series A Financing
Complement Therapeutics GmbH (CTx), a preclinical stage biotechnology company developing novel therapeutics for complement mediated diseases, today announced the completion of a €72 million Series A financing.
CareLoop Health Graduates from KQ LABS, the Digital Health Accelerator Programme
CareLoop Health, a digital therapeutics company using software to transform mental healthcare, has graduated from the esteemed KQ Labs Accelerator Programme.
Two Innovation Factory startups included in leading European top ten list of young tech spinout companies
Two startup businesses from the University of Manchester Innovation Factory have been named in a top ten of ‘university spinouts to watch’. The list is in Sifted, Europe’s influential media monitor of European tech startups. Backed by the Financial Times, Sifted is the leading media brand for the European startup community.
TenU Appoints New President
TenU, the collaboration of leading UK, US and mainland European technology transfer organisations, has appointed Andrew Wilkinson, CEO of the University of Manchester Innovation Factory, as its new president. Andrew takes over the role from Anne Lane, CEO of UCL’s technology transfer company UCLB.
Recruitment underway for significant asthma technology study at University of Manchester
Recruitment is underway for a significant research study examining how asthma technology, developed by British respiratory health technology start-up Clin-e-cal, influences inhaler technique and asthma symptoms. The randomised clinical study, which is funded through an Asthma + Lung UK and NIHR research grant, is being led by Professor Clare Murray, professor of paediatric respiratory medicine at the University of Manchester, and Asthma Programme Lead at the NIHR Manchester Biomedical Research Centre.
Another Impressive Financial Year for Manchester-Born Spinouts
Ten brand new Manchester-based biomedical, science and engineering companies have been created over the past year by The University of Manchester Innovation Factory, producing cutting-edge technology and services which will benefit societies around the world.
CareLoop Health accepted on prestigious digital health accelerator programme
Digital Therapeutics spinout, CareLoop Health, joins KQ Labs programme, for exciting early-stage start-ups using data as a core part of their business model to improve human health.
Watercycle Technologies wins Innovate UK grant for lithium extraction
Watercycle Technologies has won a £500,000 Innovate UK Smart Grant, in partnership with Cornish Lithium, to test its ground-breaking direct lithium extraction (DLE) process in Cornwall.
Innovation Factory signs MoU with SRTIP
The Innovation Factory has recently signed an MoU with SRTIP, Sharjah Research, Technology and Innovation Park (SRTIP, which will lead to acceleration of global impact.
MHRA awards Complement Therapeutics Innovation Passport for CTx001 to accelerate Gene Therapy for Geographic Atrophy
Phagenesis Launches Phagenyx Neurostimulation System in the U.S.
Phagenesis Ltd has announced that the U.S. Food and Drug Administration (FDA) has granted a De Novo request for the Phagenyx® Neurostimulation System, a first-of-its-kind therapy that uses pharyngeal electrical stimulation to restore swallowing control in patients with severe dysphagia post stroke. The company is now preparing a targeted launch in the U.S.
Graphene electrode - water molecule splitting
Scientists discover they can pull water molecules apart using graphene electrodes
Mi-Trial Launches Innovative New Clinical Trials App And Portal To Improve Trial Participation And Outcomes
Mi-Trial, a new company which has developed an innovative clinical trial companion system and app, has recently spun out from the University of Manchester with support from Elaros 24/7 Limited, Medicines Evaluation Unit Limited and the University of Manchester Innovation Factory.
Northern Gritstone backs spinout, Imperagen: a University of Manchester Life Science Business
Imperagen has developed a unique technology to accelerate the design, optimisation, and validation of novel enzymes for large molecular drug discovery. Northern Gritstone, along with IQ Capital, has led a £3.5 million Seed Round to fund the initial spin out of Imperagen from University of Manchester.
Ideas with Impact Partners Programme
Do you have an idea with great potential for global impact? Do you have financial obstacles that you need to overcome? Welcome to Ideas with Impact, where philanthropy accelerates the growth of the brightest ideas.